196 related articles for article (PubMed ID: 35709886)
21. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
[TBL] [Abstract][Full Text] [Related]
22. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
23. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
24. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
25. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
26. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
[TBL] [Abstract][Full Text] [Related]
28. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
29. Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies.
Imarisio A; Ferrari E; Pilotto A; Di Luca M; Padovani A; Gardoni F
Neurodegener Dis; 2022; 22(1):7-14. PubMed ID: 35940118
[TBL] [Abstract][Full Text] [Related]
30. Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit.
Tozzi A; de Iure A; Bagetta V; Tantucci M; Durante V; Quiroga-Varela A; Costa C; Di Filippo M; Ghiglieri V; Latagliata EC; Wegrzynowicz M; Decressac M; Giampà C; Dalley JW; Xia J; Gardoni F; Mellone M; El-Agnaf OM; Ardah MT; Puglisi-Allegra S; Björklund A; Spillantini MG; Picconi B; Calabresi P
Biol Psychiatry; 2016 Mar; 79(5):402-414. PubMed ID: 26392130
[TBL] [Abstract][Full Text] [Related]
31. Reduction of Lewy Body Pathology by Oral Cinnamon.
Raha S; Dutta D; Roy A; Pahan K
J Neuroimmune Pharmacol; 2021 Sep; 16(3):592-608. PubMed ID: 32889602
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of α-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity.
Yang J; Hertz E; Zhang X; Leinartaité L; Lundius EG; Li J; Svenningsson P
Neurosci Lett; 2016 Jan; 611():51-8. PubMed ID: 26610904
[TBL] [Abstract][Full Text] [Related]
33. Pathological biochemistry of alpha-synucleinopathy.
Iwatsubo T
Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
[TBL] [Abstract][Full Text] [Related]
34. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
35. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
[TBL] [Abstract][Full Text] [Related]
36. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
37. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
[TBL] [Abstract][Full Text] [Related]
38. In vitro modulation of mTOR and mGlur5 influence α-synuclein accumulation.
Xing V; Biggar K; Ferguson SSG; Hayley S
Mol Brain; 2024 Feb; 17(1):9. PubMed ID: 38360671
[TBL] [Abstract][Full Text] [Related]
39. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
40. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
